Clinical Statements

Filter Standards and Guidance documents

CEU Statement: Contraception advice for individuals travelling to Brazil for the 2016 Olympics and their partners (revised 28 July 2016)

28 July 2016

After reviewing the available body of evidence, the Centers for Disease Control (CDC) in the USA have concluded that a causal relationship exists between prenatal Zika virus infection and microcephaly and other serious brain anomalies. Cases of locally-transmitted Zika virus are still being reported in Brazil and most of its neighbouring countries.

This document is up-to-date

CEU Statement: Intravascular insertion of Nexplanon® - June 2016

01 June 2016

This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD to healthcare professionals in the UK regarding a small number of reports of Nexplanon contraceptive implants inadvertently inserted into blood vessels.

This document is up-to-date

CEU Statement: Sodium Valproate and Pregnancy Risks (February 2016)

01 February 2016

The Medicines and Healthcare products Regulatory Agency (MHRA) recently launched a toolkit for healthcare professionals (HCPs) regarding sodium valproate in order to communicate its teratogenic effects. The CEU recommends that all HCPs be prepared to provide information about and access to effective contraception for women who have undergone treatment with valproate-related medicines.

This document is up-to-date

CEU Statement: Response to the BMJ paper by Mao et. al. (October 2015)

01 October 2015

A large observational study from the United States found that the risk of unintended pregnancy after Essure sterilisation was similar to that after surgical sterilisation. However just over 2% of women who had Essure sterilisation required a further operation related to the sterilisation procedure within a year.

This document is up-to-date

CEU Statement: Quick Starting After UPA (September 2015)

01 September 2015

Faculty of Sexual and Reproductive Healthcare (FSRH) response to new data on quickstarting hormonal contraception after use of ulipristal acetate 30mg (ellaOne®) for emergency contraception Sept 2015.

This document is up-to-date